June 2026
- Prehospital Whole Blood for Traumatic Hemorrhage — Consistent Evidence from Two Randomized Trials
- Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
- Chromoblastomycosis
- Management of Differentiated Thyroid Cancer
- Zorevunersen in Children and Adolescents with Dravet Syndrome
- Stemness as the Engine of Checkpoint Durability
- Case 17-2026: A 74-Year-Old Man with Pancytopenia
- Is Change Possible?
- Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy
- Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
- The Social Contract of Bundibugyo Ebola Isolation
- Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?
- The OMB and the Politicization of Science
- Immunosuppression-Associated Peripheral T-Cell Lymphoma
- Patient-Driven Care in Psychedelic Therapy
- The Convergence of Down Syndrome and Alzheimer’s Disease — Scientific and Ethical Imperatives
- Psychedelic Therapies in the United States — Balancing State and Federal Oversight
- “In One Year, I Want You Alive”
- Talquetamab–Daratumumab in Relapsed or Refractory Myeloma
- Clinical Long-Read Genome Sequencing for Rare-Disease Diagnostics
- Lonvoguran Ziclumeran — In Vivo CRISPR Gene Editing in Hereditary Angioedema
- Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock
- Vasopressors or Fluids in Early Septic Shock
- Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease
- Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery
- TRACTION for Greater Surgical Use of Tranexamic Acid
- Carbocisteine or Hypertonic Saline for Acute Respiratory Failure
- Supporting Access to Reliable Health Information with Public–Private Collaboration
- Conservative Oxygen for Unresponsive Patients after Cardiac Arrest
- Survodutide Once Weekly for the Treatment of Adults with Obesity
- Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
- Finerenone in Persons with Chronic Kidney Disease without Diabetes
- Sudan Virus Disease in Uganda, 2025
- Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda
- Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
- Emerging Era for Polymyalgia Rheumatica and GCA — Interleukin-17A Targeting
- Obexelimab for the Treatment of IgG4-Related Disease
- Obexelimab and the Promise of Nondepleting B-Cell Therapy in IgG4-Related Disease
- Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
- Perioperative Apalutamide in High-Risk Localized Prostate Cancer
- Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer
- A Watershed Moment in the Perioperative Treatment of Prostate Cancer
- PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer
- Precision Intensification in Metastatic Prostate Cancer
- Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
- First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
- Redefining Early Relapse in Multiple Myeloma — Time to Change the Rules
- Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
- A Major Step toward a Cure for Hepatitis B Infection
- NEJM Outbreaks Update — Andes Hantavirus